Publications & Events
upward view of the building
Webinar

Global pharmaceuticals: New horizons in a post-COVID world

At this webinar, our expert panel of speakers discussed what lies ahead for the pharmaceutical industry and those it affects —from the extraordinary international collaboration in the wake of the COVID-19 pandemic to drive innovation, to tackling vaccine nationalism, data and supply chain issues, and managing surge capacity. They also considered where the next opportunities may be, and how companies can position themselves for growth and new opportunities while navigating a complex political landscape in which reputational risks are high.

Watch in full: "Global pharmaceuticals: New horizons in a post-COVID world"

 

See findings from the webinar presented in the graphic below.

 

Moderator

 
Sarah Neville
Sarah Neville
Global Health Editor, Financial Times
   
Speakers  
   
Robert Langer
Dr. Robert Langer
Co-founder of Moderna
Koen Berden
    
Dr. Koen Berden
Executive Director of International Affairs
at EFPIA
Keith Flanagan
Keith Flanagan
Consultant, former FDA Director
of New Drug Policy
Anita Varma
Anita Varma
Partner, White & Case
James Killick

James Killick
Partner, White & Case

Victoria Landsbert
Victoria Landsbert
Partner, White & Case

 

Spring Webinar series